Radioligand therapy for breast cancer isn’t science fiction—it’s science that’s finally starting to catch up with the need. The potential is enormous. The stakes are high. And the urgency is real…If we do this right, we’ll not only give patients more time—but more quality time. And that, after all, is the point.